Eva-Hip, Evaluation of Rehabilitation After Hip-fracture (Eva-Hip)

This study is ongoing, but not recruiting participants.
Trondheim Kommune
Norsk kvinners sanitetsforening
Information provided by (Responsible Party):
Norwegian University of Science and Technology
ClinicalTrials.gov Identifier:
First received: June 15, 2011
Last updated: September 29, 2015
Last verified: September 2015
To evaluate the effect on gait and activity of a home based physiotherapy intervention 4-6 months after the fracture. The investigators hypothesis is that exercises performed after the initial rehabilitation, which focuses on specific components of gait control will improve gait and increase level of activity.

Condition Intervention Phase
Hip Fracture
Procedure: physiotherapy
Phase 1
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: The Effect on Gait and Activity Level of a Physiotherapy Intervention Aimed at Improving Mediolateral Stability 4 Months After a Hip Fracture

Resource links provided by NLM:

Further study details as provided by Norwegian University of Science and Technology:

Primary Outcome Measures:
  • change in gait speed [ Time Frame: 4,6 and 12 months postfracture ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • change in activity level [ Time Frame: 4,6 and 12 month postfracture ] [ Designated as safety issue: No ]

Enrollment: 223
Study Start Date: February 2011
Estimated Study Completion Date: December 2016
Estimated Primary Completion Date: June 2016 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: physiotherapy
Procedure: physiotherapy
exercises, 20 sessions over 10 weeks
No Intervention: conventional treatment
care as usual


Ages Eligible for Study:   70 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Home dwelling prior to fracture
  • age>70yr
  • able to walk 10m

Exclusion Criteria:

  • expected life expectancies <3 months
  • exercises contraindicated due to medical conditions
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01379456

Norwegian University of Science and Technology
Trondheim, Norway, 7006
Sponsors and Collaborators
Norwegian University of Science and Technology
Trondheim Kommune
Norsk kvinners sanitetsforening
Principal Investigator: Olav Sletvold, MD,PHD Department of Neuroscience, Norwegian University of Science and Technology
  More Information

Responsible Party: Norwegian University of Science and Technology
ClinicalTrials.gov Identifier: NCT01379456     History of Changes
Other Study ID Numbers: REK 2010/3265-3 
Study First Received: June 15, 2011
Last Updated: September 29, 2015
Health Authority: Norway:National Committee for Medical and Health Research Ethics
Norway: Norwegian Social Science Data Services

Additional relevant MeSH terms:
Fractures, Bone
Hip Fractures
Femoral Fractures
Hip Injuries
Leg Injuries
Wounds and Injuries

ClinicalTrials.gov processed this record on May 25, 2016